Michigan, along with other states, reached settlements with drug manufacturers, distributors, and pharmacies for their role in the opioid epidemic. These funds are designated to support treatment, prevention, recovery, and harm reduction.
Currently, the Michigan is set to receive $1.6 billion. This amount is split evenly between state government and local governments.
Funding is equally split between the state and local governments. The state is investing in a series of strategic initiatives to respond to immediate needs of community and improve the sustainable infrastructure of substance us response in the state,
While representing only a portion of what the state spends on substance use response, settlement investments are helping establish Michigan as a national leader.
More information on accomplishments: Investment-Summary-and-Progress-6_11_2025.pdf
More data on progress: Settlement Data
More about investments: Settlement Spending
The Michigan Opioid Task Force leads the state's coordinated response to the opioid epidemic. Through cross-agency collaboration and community engagement, the task force develops strategies, policies, and programs to reduce overdose deaths and support recovery across Michigan. This work reflects Governor Gretchen Whitmer’s ongoing commitment to addressing the opioid crisis.
MDHHS, with support of the task force, developed a substance use framework to invest in prevention, harm reduction, treatment, and recovery support services. The goal is to leverage these investments to reduce overdose deaths and address disparities.
Policy plays a critical role in substance use response. From legislation to organizational policy, an improved policy environment will ensure strategic investments and the work happening in communities have maximum impact
March 3, 2026 |
Prevention Grant Funding Opportunity (GFO)Funding will support community-based programs that target youth ages 12 to 17 to help delay the start of alcohol, tobacco, and other drug use. Approaches may include programs designed to strengthen families, expand access to positive out of school activities, build youth decision-making skills, and create safe and supportive environments. Deadline for proposals: 3:00 p.m. April 2, 2026. Anticipated grant start date: June 1, 2026 For more information or to apply, visit the EGrAMS website. The full grant opportunity and supporting documents can be found under “Current Grants” in the “Specialty Behavioral Health Services” section by selecting the “PSUPS-2026” program |
February 27, 2026 |
Request for Proposals (RFP) for Round 2 of the Recovery Housing Investment Program (RHIP)In partnership with the Michigan Department of Health and Human Services (MDHHS), the Michigan State Housing Development Authority (MSHDA) will award funds will to be used to purchase and/or lease single family homes or multifamily properties to expand access to recovery housing for individuals with opioid use disorder (OUD)/substance use disorder (SUD) or co-occurring mental health conditions. Deadline for proposals: Thursday, April 16, 2026. Anticipated grant start date: June 1, 2026. Questions may be directed to Zienab Fahs: fahsz@michigan.gov. Please use subject line “RHIP RFP Questions”. |
January 5, 2026 |
New Funding Opportunity! The Recovery Support Services Competitive grant funding opportunity (GFO)The purpose of these funds is to expand recovery support center services or recovery community center services for individuals seeking long-term recovery from substance use disorders. A total of $3.9 million is available with a maximum award of $150,000. MDHHS anticipates issuing up to 26 awards. Grant applications must be submitted electronically through the EGrAMS program by 3 p.m., Friday, Jan 30. The program period begins March 1, 2026, and ends Sept. 30, 2026. For more information or to apply, visit the EGrAMS website. |
Upcoming Events: |
June 9th, 2025Mobile Health Units Providing Medications for Opioid Use Disorder: The Experiences of Quality Behavioral Health (QBH) Time: 1:00 - 2:00 PM Description: Mobile units offering medications for opioid use disorder (MOUD) are an effective strategy for expanding access to care—particularly for underserved populations such as individuals experiencing homelessness, those with transportation or scheduling challenges, minoritized communities, and people recently released from incarceration. In this webinar, Quality Behavioral Health’s Katherine Blakley, MSW President and Chief Executive Officer, and Naveed Syed, MA, MBA, CAC-M, CCS-M, CPS-M, will share insights from launching their mobile methadone program in 2023, including key steps in the implementation process and lessons learned along the way. Presenters:
Register Here |
Past Technical Assistance Collaborative webinars can all be viewed at our Opioid Settlement Resources Page |
